In nonalcoholic steatosis, transgenic mice containing an aP2 promoter-driven GPNMB overexpression showed decreased fat accumulation and fibrosis in the liver in an obesity model when compared to obese D2 mice (63). The gene discussed is GPNMB; the disease is obesity due to melanocortin 4 receptor deficiency.